Anti-HIV effect of liposomes bearing CXCR4 receptor antagonist N15P

Tropical Journal of Pharmaceutical Research

Volumn 12, Issue 4, 2013, Pages 503-509

  Zhao, Yingxia ^a   Sun, Hanxiao ^a   Li, Xiuying ^a   Mo, Xuemei ^a   Zhang, Guang ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Antagonist; CXCR4; HIV; Inflammation; Liposomes; Receptor

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST N15P; LIPOSOME; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BINDING COMPETITION; CHEMOTAXIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN IMMUNODEFICIENCY VIRUS; IN VIVO STUDY; LIPOSOMAL DELIVERY; LIVER; MACACA FASCICULARIS; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SPLEEN; TISSUE DISTRIBUTION; ZETA POTENTIAL;

EID: 84883048429     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v12i4.9     Document Type: Article

References (11)

1. Mayuko Mori a, Dongxiang Liu a, Santosh Kumar a, Ziwei Huang. NMR structures of anti-HIV D-peptides derived from the N-terminus of viral chemokine vMIP-II [J]. Biochemical and Biophysical Research Communications. 2005; 335: 651-658.
2. Rawat SS, Johnson BT, Puri A. Sphingolipids: modulators of HIV-1 infection and pathogenesis[J]. Biosci Rep. 2005; 25(5-6): 329-43.
3. van der Meer P, Ulrich AM, Gonźalez-Scarano F, Lavi E. Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia [J]. Exp Mol Pathol. 2000; 69(3): 192-201.
4. De Jong LAA, Uges DRA, Franke JP, Bischoff R. Receptor-ligand binding assays: technologies and applications. J Chromatogr B. 2005; 829: 1-25.
5. Naiming Zhou N, Luo Z, Luo J, Hall JW, Huang Z. A Novel Peptide Antagonist of CXCR4 Derived from the NTerminus of Viral Chemokine vMIP-II [J]. Biochemistry 2000; 39: 3782-3787.
6. Vlahakis SR, Villasis-Keever A, Gomez T, Vanegas M, Vlahakis N, Paya CV. G protein coupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol 2006; 169: 5546-5554.
7. JinNan University Ethical Committee in accordance with Principles of Laboratory Animal Care. NIH publication no. 85-23, revised 1985
8. Majka M, Ratajczak J, Kowalska MA, Ratajczak MZ. Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT. Eur J Haematol 2010; 64: 164-172.
9. Kijowski J, Baj-Krzyworzeka M, Majka M, Reca R, Marquez LA, Christofidou Solomidou M, Janowska-Wieczorek A, Ratajczak MZ. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells 2001; 19: 453-466.
10. Bailey, G. S. In vitro labeling of proteins, in Radioisotopes in Biology, IRL, Oxford, UK. 1990: 191-205.
11. Sun H, Mo X, Yan L, Li X, Zhang G. Anti-HIV-1 Activities of rvMIP Combined with other Drugs by Real-time Polym erase Chain Reaction. Chin Pharm J, 2010; 11(45): 814-817.